UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
19.31
-0.09 (-0.46%)
At close: Aug 19, 2025, 12:08 PM
UroGen Pharma Revenue
UroGen Pharma reported an annual revenue of $90.4M, reflecting a 9.29% growth. For the quarter ending June 30, 2025, UroGen Pharma generated $24.21M in revenue.
Revenue (ttm)
90.4M
Revenue Growth
9.29%
Price / Sales Ratio
5.05
Revenue / Employee
386.32K
Employees
234
Market Cap
893.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 90.4M | +9.29% |
| Dec 31, 2023 | 82.71M | +28.52% |
| Dec 31, 2022 | 64.36M | +33.96% |
| Dec 31, 2021 | 48.04M | +307.17% |
| Dec 31, 2020 | 11.8M | +65450.00% |
| Dec 31, 2019 | 18K | -98.40% |
| Dec 31, 2018 | 1.13M | -86.17% |
| Dec 31, 2017 | 8.16M | -53.46% |
| Dec 31, 2016 | 17.53M | +Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |